Veradermics, Inc
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
State of Incorporation DE
Business Address 470 JAMES STREET, NEW HAVEN, CT, 06513
Mailing Address 470 JAMES STREET, NEW HAVEN, CT, 06513
Phone 228.372.3376
Fiscal Year End 1231
EIN 843304423
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G Passive beneficial ownership (>5%) | February 12, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | February 12, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | February 11, 2026 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | February 11, 2026 | View on SEC |
| 3 Initial insider ownership report | February 9, 2026 | View on SEC |
| 4 Insider stock transaction report | February 9, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
IPO Filings
S-1 January 9, 2026
- Developing brand-new, innovative medicines specifically for severe skin conditions using cutting-edge science.
- Showing promising growth with key drugs already on the market and new treatments in development.
Insider Trading
STRONG BUY 5 insiders
26 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.